These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 27003666)

  • 21. Pulmonary Arterial Hypertension: Combination Therapy in Practice.
    Burks M; Stickel S; Galiè N
    Am J Cardiovasc Drugs; 2018 Aug; 18(4):249-257. PubMed ID: 29511993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evolving treatment landscape of pulmonary arterial hypertension.
    Gale S
    Am J Manag Care; 2021 Mar; 27(3 Suppl):S42-S52. PubMed ID: 33710843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration.
    Hill NS; Badesch D; Benza RL; D'Eletto TA; Farber HW; Gomberg-Maitland M; Hassoun PM; Preston I
    Ann Am Thorac Soc; 2015 Feb; 12(2):269-73. PubMed ID: 25590376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current treatment strategies for pulmonary arterial hypertension.
    Lee SH; Rubin LJ
    J Intern Med; 2005 Sep; 258(3):199-215. PubMed ID: 16115293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Special Focus on Selexipag - Treatment of Pulmonary Arterial Hypertension.
    Sorensen LM; Wehland M; Kruger M; Simonsen U; Nassef MZ; Infanger M; Grimm D
    Curr Pharm Des; 2017; 23(34):5191-5199. PubMed ID: 28891448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United States.
    Burger CD; Ozbay AB; Lazarus HM; Riehle E; Montejano LB; Lenhart G; White RJ
    J Manag Care Spec Pharm; 2018 Aug; 24(8):834-842. PubMed ID: 29436260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update on medical therapy for pulmonary arterial hypertension.
    Wu Y; O'Callaghan DS; Humbert M
    Curr Hypertens Rep; 2013 Dec; 15(6):614-22. PubMed ID: 24122306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Updated treatment algorithm of pulmonary arterial hypertension.
    Galiè N; Corris PA; Frost A; Girgis RE; Granton J; Jing ZC; Klepetko W; McGoon MD; McLaughlin VV; Preston IR; Rubin LJ; Sandoval J; Seeger W; Keogh A
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D60-72. PubMed ID: 24355643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled treprostinil: a therapeutic review.
    Channick RN; Voswinckel R; Rubin LJ
    Drug Des Devel Ther; 2012; 6():19-28. PubMed ID: 22291467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary arterial hypertension: tailoring treatment to risk in the current era.
    Gaine S; McLaughlin V
    Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29263175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.
    Ruopp NF; Cockrill BA
    JAMA; 2022 Apr; 327(14):1379-1391. PubMed ID: 35412560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective.
    Gomberg-Maitland M; Dufton C; Oudiz RJ; Benza RL
    J Am Coll Cardiol; 2011 Mar; 57(9):1053-61. PubMed ID: 21349396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination Therapy in Pulmonary Arterial Hypertension-Targeting the Nitric Oxide and Prostacyclin Pathways.
    Mandras S; Kovacs G; Olschewski H; Broderick M; Nelsen A; Shen E; Champion H
    J Cardiovasc Pharmacol Ther; 2021 Sep; 26(5):453-462. PubMed ID: 33836637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary Arterial Hypertension: Pathophysiology and Treatment.
    Lan NSH; Massam BD; Kulkarni SS; Lang CC
    Diseases; 2018 May; 6(2):. PubMed ID: 29772649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin receptor antagonism: role in the treatment of pulmonary arterial hypertension related to scleroderma.
    Kabunga P; Coghlan G
    Drugs; 2008; 68(12):1635-45. PubMed ID: 18681488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of Knowledge, Attitude, and Practice Patterns in Pulmonary Arterial Hypertension among Cardiologists and Pulmonologists: Evidence from Turkey.
    Günaydın FE; Belen E; Altın S; Demir AU; Güven G; Durmuş G
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893587
    [No Abstract]   [Full Text] [Related]  

  • 38. [Targeted therapy for pulmonary arterial hypertension in patients without comorbidities].
    Klose H; Harbaum L; Richter MJ; Lichtblau M; Marra AM; Kabitz HJ; Harutyunova S; Milger-Kneidinger K; Lange TJ
    Pneumologie; 2023 Nov; 77(11):890-900. PubMed ID: 37963478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An update on the diagnosis and treatment of pediatric pulmonary hypertension.
    Olguntürk FR
    Expert Opin Pharmacother; 2020 Jul; 21(10):1253-1268. PubMed ID: 32401622
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.